Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenta Yagi

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 3, 2025
Risk factors for clazosentan-induced fluid retention in subarachnoid hemorrhage from the Japanese adverse event databaseRie Ando-Matsuoka, Kei Kawada, Takahiro Niimura, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2025
<i>Atractylodes lancea</i> (Thunb.) DC. [Asteraceae] Rhizome-Derived Exosome-like Nanoparticles Suppress Lipopolysaccharide-Induced Inflammation by Reducing Toll-like Receptor 4 Expression in BV-2 Murine Microglial CellsMizusa Hyodo, Kei Kawada, Tomoaki Ishida, et al.
Frontiers in Cardiovascular Medicine|June 17, 2024
Effects of renin-angiotensin system inhibitor and beta-blocker use on mortality in older patients with heart failure with reduced ejection fraction in JapanKei Kawada, Tomoaki Ishida, Hitoshi Fukuda, et al.
Cancer Medicine|November 24, 2020
Investigation of drugs affecting hypertension in bevacizumab-treated patients and examination of the impact on the therapeutic effectKenta Yagi, Marin Mitstui, Yoshito Zamami, et al.
Clinical and Translational Science|April 21, 2022
Discovery of preventive drugs for cisplatin-induced acute kidney injury using big data analysisMasaya Kanda, Mitsuhiro Goda, Akiko Maegawa, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 18, 2023
Angiogenesis inhibitor-specific hypertension increases the risk of developing aortic dissectionKaito Tsujinaka, Yuki Izawa-Ishizawa, Koji Miyata, et al.
Drug Development Research|December 9, 2022
Differential effects of proton pump inhibitors and vonoprazan on vascular endothelial growth factor expression in cancer cellsRie Ando-Matsuoka, Kenta Yagi, Mayu Takaoka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 9, 2022
Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality AnalysisMasayuki Chuma, Aki Nakamoto, Takashi Bando, et al.
European Journal of Pharmacology|June 6, 2022
Investigation of drugs for the prevention of doxorubicin-induced cardiac events using big data analysisShiori Nishiuchi, Kenta Yagi, Hiroumi Saito, et al.
Acta Medica Okayama|December 25, 2023
Concomitant Use of Multiple Nephrotoxins including Renal Hypoperfusion Medications Causes Vancomycin-Associated Nephrotoxicity: Combined Retrospective Analyses of Two Real-World DatabasesTakashi Bando, Masayuki Chuma, Hirofumi Hamano, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 3, 2025
Risk factors for clazosentan-induced fluid retention in subarachnoid hemorrhage from the Japanese adverse event databaseRie Ando-Matsuoka, Kei Kawada, Takahiro Niimura, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2025
<i>Atractylodes lancea</i> (Thunb.) DC. [Asteraceae] Rhizome-Derived Exosome-like Nanoparticles Suppress Lipopolysaccharide-Induced Inflammation by Reducing Toll-like Receptor 4 Expression in BV-2 Murine Microglial CellsMizusa Hyodo, Kei Kawada, Tomoaki Ishida, et al.
Frontiers in Cardiovascular Medicine|June 17, 2024
Effects of renin-angiotensin system inhibitor and beta-blocker use on mortality in older patients with heart failure with reduced ejection fraction in JapanKei Kawada, Tomoaki Ishida, Hitoshi Fukuda, et al.
Cancer Medicine|November 24, 2020
Investigation of drugs affecting hypertension in bevacizumab-treated patients and examination of the impact on the therapeutic effectKenta Yagi, Marin Mitstui, Yoshito Zamami, et al.
Clinical and Translational Science|April 21, 2022
Discovery of preventive drugs for cisplatin-induced acute kidney injury using big data analysisMasaya Kanda, Mitsuhiro Goda, Akiko Maegawa, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 18, 2023
Angiogenesis inhibitor-specific hypertension increases the risk of developing aortic dissectionKaito Tsujinaka, Yuki Izawa-Ishizawa, Koji Miyata, et al.
Drug Development Research|December 9, 2022
Differential effects of proton pump inhibitors and vonoprazan on vascular endothelial growth factor expression in cancer cellsRie Ando-Matsuoka, Kenta Yagi, Mayu Takaoka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 9, 2022
Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality AnalysisMasayuki Chuma, Aki Nakamoto, Takashi Bando, et al.
European Journal of Pharmacology|June 6, 2022
Investigation of drugs for the prevention of doxorubicin-induced cardiac events using big data analysisShiori Nishiuchi, Kenta Yagi, Hiroumi Saito, et al.
Acta Medica Okayama|December 25, 2023
Concomitant Use of Multiple Nephrotoxins including Renal Hypoperfusion Medications Causes Vancomycin-Associated Nephrotoxicity: Combined Retrospective Analyses of Two Real-World DatabasesTakashi Bando, Masayuki Chuma, Hirofumi Hamano, et al.
Pageof 7